Dr. Mustafa Khasraw, M.D.
Claim this profileDuke University Medical Center
Studies Brain Tumor
Studies Glioblastoma
10 reported clinical trials
15 drugs studied
Area of expertise
1Brain Tumor
IDH positive
MET positive
Stage IV
2Glioblastoma
MET positive
MET negative
EGFR positive
Affiliated Hospitals
Clinical Trials Mustafa Khasraw, M.D. is currently running
Peptide Vaccine
for Brain Cancer
This trial tests a new vaccine called P30-EPS in patients with a specific type of aggressive brain cancer. The vaccine helps the immune system recognize and attack cancer cells by using three special proteins.
Recruiting1 award Phase 111 criteria
Fluoxetine + Chemotherapy
for Brain Cancer
This trial is testing whether fluoxetine, a common antidepressant, can help improve the effectiveness of a chemotherapy drug called temozolomide (TMZ) in patients with recurrent brain cancer. The study focuses on patients whose cancer has returned and who are undergoing surgery. Fluoxetine is thought to make certain cell parts work harder, which helps TMZ kill cancer cells more effectively. Fluoxetine (Prozac) is one of the most frequently prescribed antidepressants in the United States and has been studied for its effects on depression in cancer patients.
Recruiting1 award Phase < 1
More about Mustafa Khasraw, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mustafa Khasraw, M.D. has experience with
- Temozolomide
- HEGFRvIII-CD3 (BRiTE)
- Evolocumab
- CDX-527
- Berubicin
- Lomustine
Breakdown of trials Mustafa Khasraw, M.D. has run
Brain Tumor
Glioblastoma
Malignant Glioma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mustafa Khasraw, M.D. specialize in?
Mustafa Khasraw, M.D. focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are MET positive.
Is Mustafa Khasraw, M.D. currently recruiting for clinical trials?
Yes, Mustafa Khasraw, M.D. is currently recruiting for 3 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Mustafa Khasraw, M.D. has studied deeply?
Yes, Mustafa Khasraw, M.D. has studied treatments such as Temozolomide, hEGFRvIII-CD3 (BRiTE), Evolocumab.
What is the best way to schedule an appointment with Mustafa Khasraw, M.D.?
Apply for one of the trials that Mustafa Khasraw, M.D. is conducting.
What is the office address of Mustafa Khasraw, M.D.?
The office of Mustafa Khasraw, M.D. is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.